Tackling variability in CNS clinical trials: Enhancing data reliability in neuroscience studies through structured rater training and integrated eCOA solutions.
Central Nervous System (CNS) clinical trials are among the most complex to execute, with subjective endpoints and rater-dependent assessments introducing significant variability into study data. This variability can compromise data quality, increase operational burden, and ultimately impact the success of the trial.
Watch the webinar replay to explore how structured rater training and integrated eCOA solutions can reduce variability in CNS trials, improve data consistency, and support more reliable outcomes and inspection readiness.
Daniel Herron & Estelle Haenel
Global VP, Digital Health @RWS Group & CMO @Kayentis
Proven approaches to reducing rater variability in complex CNS studies.
Ask Daniel Herron and Estelle Haenel your questions directly during the session.
With a strong focus on strategic initiatives and building trusted customer relationships, Dan leads efforts to bring innovative technology solutions to life sciences organisations, helping accelerate better outcomes for patients worldwide.
Joined Kayentis as Chief Medical Officer in 2019 – She has 25+ years of experience in pre-clinical and clinical research in Top 5 Pharma and Biotech companies. A Doctor of Pharmacy, Estelle also has Masters in Endocrinology and Cellular Interaction and a PhD in Biochemistry and Molecular Biology.
As host and moderator, Peter will lead the session, facilitating expert discussion and ensuring a valuable experience, with opportunities for participants to ask questions and engage.
